Theraclion Balance Sheet Health
Financial Health criteria checks 5/6
Theraclion has a total shareholder equity of €3.3M and total debt of €7.9M, which brings its debt-to-equity ratio to 240.9%. Its total assets and total liabilities are €14.9M and €11.6M respectively.
Key information
240.9%
Debt to equity ratio
€7.91m
Debt
| Interest coverage ratio | n/a |
| Cash | €5.90m |
| Equity | €3.28m |
| Total liabilities | €11.58m |
| Total assets | €14.86m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TCLI.F's short term assets (€12.4M) exceed its short term liabilities (€2.6M).
Long Term Liabilities: TCLI.F's short term assets (€12.4M) exceed its long term liabilities (€9.0M).
Debt to Equity History and Analysis
Debt Level: TCLI.F's net debt to equity ratio (61.3%) is considered high.
Reducing Debt: TCLI.F had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TCLI.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TCLI.F has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 8.8% each year.